Pure Global AI
NCT06421896Recruiting

Motivational Enhancement Therapy's Impact on d COPD Outcomes in Geriatric Patient

Exploring the Motivational Enhancement Therapy's Impact on Motivation, Resilience, Anxiety Reduction, and COPD Outcomes in Geriatric Patient
Alexandria UniversityClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
COPD
Drug/Device/Intervention
motivational Enhancement Therapy
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Alexandria University
Location
Alexandria, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Oct 01, 2024
Enrollment
100 participants
Primary outcome

COPD geriatric patients who entered motivational Enhancement Therapy will demonstrate a higher score in resilience scale ( ( total score range from 15 to 75, a higher score of more than 50)than those who not entered

Summary

Motivational Enhancement Therapy (MET) is a systematic intervention that focuses on eliciting
 and strengthening a person's intrinsic motivation to change. MET is rooted in motivational
 interviewing principles, emphasizing empathy, autonomy, and the evocation of the patient's
 own motivations for change. The therapy typically involves several sessions where therapists
 help patients identify personal goals, explore ambivalence towards change, and develop
 actionable plans to achieve their desired outcomes.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedPulmonary heart disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06421896
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06421896 through Pure Global AI's free database. This phase not specified trial is sponsored by Alexandria University and is currently Recruiting. The study focuses on COPD. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.